C Hochfellner, D Evangelopoulos, M Zloh, A Wube, J D Guzman, T D McHugh, O Kunert, S Bhakta, F Bucar
文献索引：J. Appl. Microbiol. 118(4) , 864-72, (2015)
全文：HTML全文
The interaction of quinolone and indoloquinazoline alkaloids concerning their antimycobacterial activity was studied.The antimycobacterial and modulating activity of evodiamine (1), rutaecarpine (2) and evocarpine (3) was tested on mycobacteria including three multidrug-resistant (MDR) clinical isolates of Mycobacterium tuberculosis. Antagonistic effects were concluded from fractional inhibitory concentration (FICI) values. Interaction energies of the compounds were calculated using GLUE docking module implemented in GRID. 1 and 2 exhibited weak inhibition of rapidly growing mycobacteria, however, 1 was active against Myco. tuberculosis H37Rv (MIC = 10 mg l(-1) ) while 2 was inactive. Both 1 and 2 showed a marked antagonistic effect on the susceptibility of different mycobacterial strains to 3 giving FICI values between 5 and 9. The interaction energies between compounds 1 and 2 with compound 3 suggested the possibility of complex formation in solution.Indoloquinazoline alkaloids markedly reduce the antimycobacterial effect of the quinolone alkaloid evocarpine. Complex formation may play a role in the attenuation of its antimycobacterial activity.This study gives a striking example of antagonism between compounds present in the same plant extract which should be considered in natural product based screening projects.© 2015 The Society for Applied Microbiology.
